Covid-19: SA's Aspen could produce J&J vaccine shots by end of March

accreditation
0:00
play article
Subscribers can listen to this article
Another vaccine could soon be available in SA.
Another vaccine could soon be available in SA.
Photo by BRENDAN SMIALOWSKI/AFP via Getty Images
  • Aspen Pharmacare could start production of the Johnson & Johnson Covid-19 vaccines in SA by late March, early April
  • All vaccines produced will be exported to J&J. 
  • Aspen has current capacity to manufacture up to 300 million doses of the vaccine.

Aspen Pharmacare could start production of Johnson & Johnson (J&J) Covid-19 vaccines in South Africa by late March or early April if all approvals are in place, a senior company executive said.

All the vaccines produced will be exported to J&J and will be a part of its global supply inventory, Stavros Nicolaou, Group Senior Executive, Strategic Trade at Aspen said.

"We are going to receive a tech transfer to contract manufacture for them (J&J)... Aspen has current capacity to manufacture up to 300 million doses of [the] Covid-19 vaccine," Nicolaou said in an interview with Reuters on Thursday, adding that these would be exported to J&J.

South Africa's government is in talks with J&J in an effort to secure some of this product for its own consumption. J&J is in the final phase of its clinical trials and is likely to announce results by the end of January, Nicolaou added.

J&J did not reply to an email from Reuters seeking comment. South Africa's health ministry did not respond to an email seeking comment.

ALSO READ | A cancelled meeting, delays and secrecy: Inside SA's efforts to procure Covid-19 vaccine doses

The government has been criticised by scientists and healthcare workers for moving too slowly to procure Covid-19 vaccines to inoculate South Africans.

Health Minister Zweli Mkhize said on Thursday that South Africa plans to get its first vaccines in February and could vaccinate up to 40 million people over a year to reach herd immunity.

But the government has not signed any big bilateral deals with any of the vaccine manufacturers, although it said the country would get 1.5 million vaccines from the Serum Institute of India (SII).

The government is also sourcing vaccines from the Covax Facility, a global distribution scheme under which South Africa will start getting vaccines by the second quarter of 2021 for 10% of its population of 58 million.

Nicolaou said he was not privy to the status of the negotiations, but the government had requested that Aspen "impress upon" J&J to set aside some vaccines.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
Are you going to keep wearing a mask following the announcement that it is no longer required under law?
Please select an option Oops! Something went wrong, please try again later.
Results
No ways, I'm done
39% - 4630 votes
Yes, I still want to be cautious
26% - 3011 votes
Only certain circumstances
35% - 4136 votes
Vote
Rand - Dollar
16.09
-1.4%
Rand - Pound
19.60
-0.7%
Rand - Euro
16.93
-0.9%
Rand - Aus dollar
11.12
-1.3%
Rand - Yen
0.12
-0.9%
Gold
1,819.88
-0.2%
Silver
20.81
-1.7%
Palladium
1,874.89
+0.1%
Platinum
913.50
+0.2%
Brent Crude
115.09
+1.7%
Top 40
61,789
+0.4%
All Share
68,058
+0.3%
Resource 10
66,069
+0.9%
Industrial 25
80,452
+0.3%
Financial 15
15,394
-0.2%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE